Ketanserin: A novel cardiovascular drug
1986
Extensive clinical investigation has shown that ketanserin is an effective first-line antihypertensive agent with particular advantages in older patients. It has a favorable hemodynamic profile and seems devoid of serious side-effects. Clinical studies in various diseases indicate a gradual improvement of the microcirculation, which is compatible with selective serotonin S2-antagonism. Ketanserin has a favorable influence on several cardiovascular risk factors. Preliminary data suggest that it has vascular protective effects in patients with atherosclerosis.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
50
References
13
Citations
NaN
KQI